For: | Dai Y, Wang WH. Peroxisome proliferator-activated receptor γ and colorectal cancer. World J Gastrointest Oncol 2010; 2(3): 159-164 [PMID: 21160824 DOI: 10.4251/wjgo.v2.i3.159] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v2/i3/159.htm |
Number | Citing Articles |
1 |
Joseph Vamecq, Jean-Marie Colet, Jean Jacques Vanden Eynde, Gilbert Briand, Nicole Porchet, Stéphane Rocchi. PPARs: Interference with Warburg’ Effect and Clinical Anticancer Trials. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/304760
|
2 |
Simran Kaur, Alo Nag, Gurudutta Gangenahalli, Kulbhushan Sharma. Peroxisome Proliferator Activated Receptor Gamma Sensitizes Non-small Cell Lung Carcinoma to Gamma Irradiation Induced Apoptosis. Frontiers in Genetics 2019; 10 doi: 10.3389/fgene.2019.00554
|
3 |
Leandro Kasuki, Bernardo Maia, Mônica R. Gadelha. Acromegaly and Colorectal Neoplasm: An Update. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.924952
|
4 |
Sheril Alex, Katja Lange, Tom Amolo, Jeffrey S. Grinstead, Anders K. Haakonsson, Ewa Szalowska, Arjen Koppen, Karin Mudde, Daniëlle Haenen, Sa'ad Al-Lahham, Han Roelofsen, René Houtman, Bart van der Burg, Susanne Mandrup, Alexandre M. J. J. Bonvin, Eric Kalkhoven, Michael Müller, Guido J. Hooiveld, Sander Kersten. Short-Chain Fatty Acids Stimulate Angiopoietin-Like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor γ. Molecular and Cellular Biology 2013; 33(7): 1303 doi: 10.1128/MCB.00858-12
|
5 |
Laura De Lellis, Annamaria Cimini, Serena Veschi, Elisabetta Benedetti, Rosa Amoroso, Alessandro Cama, Alessandra Ammazzalorso. The Anticancer Potential of Peroxisome Proliferator‐Activated Receptor Antagonists. ChemMedChem 2018; 13(3): 209 doi: 10.1002/cmdc.201700703
|
6 |
Hatim Boughanem, Amanda Cabrera-Mulero, Pablo Hernández-Alonso, Borja Bandera-Merchán, Alberto Tinahones, Francisco José Tinahones, Sonsoles Morcillo, Manuel Macias-Gonzalez. The Expression/Methylation Profile of Adipogenic and Inflammatory Transcription Factors in Adipose Tissue Are Linked to Obesity-Related Colorectal Cancer. Cancers 2019; 11(11): 1629 doi: 10.3390/cancers11111629
|
7 |
Eleonore Fröhlich, Richard Wahl. Chemotherapy and Chemoprevention by Thiazolidinediones. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/845340
|
8 |
Anna Panza, Valerio Pazienza, Maria Ripoli, Giorgia Benegiamo, Annamaria Gentile, Maria Rosaria Valvano, Bartolomeo Augello, Giuseppe Merla, Clelia Prattichizzo, Francesca Tavano, Elena Ranieri, Pierluigi di Sebastiano, Manlio Vinciguerra, Angelo Andriulli, Gianluigi Mazzoccoli, Ada Piepoli. Interplay between SOX9, β-catenin and PPARγ activation in colorectal cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2013; 1833(8): 1853 doi: 10.1016/j.bbamcr.2013.04.004
|
9 |
Tejal Pant, Nikita Aware, Padma V. Devarajan, Ratnesh Jain, Prajakta Dandekar. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. AAPS Advances in the Pharmaceutical Sciences Series 2019; 39: 141 doi: 10.1007/978-3-030-29168-6_5
|
10 |
Mei Han, Hui Gao, Ping Ju, Ming-quan Gao, Yin-ping Yuan, Xue-hong Chen, Kai-li Liu, Yan-tao Han, Zhi-wu Han. RETRACTED: Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ. Biomedicine & Pharmacotherapy 2018; 103: 272 doi: 10.1016/j.biopha.2018.04.014
|
11 |
Maral Hajipour, Khatereh Mokhtari, Mohammad Mahdevar, Maryam Esmaeili, Maryam Peymani, Mohammad Hossein Nasr-Esfahani, Sepideh Mirzaei, Mehrdad Hasehmi, Kiavash Hushmandi, Kamran Ghaedi. Identification of a novel interplaying loop of PPARγ and respective lncRNAs are involved in colorectal cancer progress. International Journal of Biological Macromolecules 2022; 219: 779 doi: 10.1016/j.ijbiomac.2022.07.247
|
12 |
Lijuan He, Dong Shen, Jianmei Li, Weidong Mao. RETRACTED:Alpinumisoflavone suppresses human Glioblastoma cell growth and induces cell cycle arrest through activating peroxisome proliferator‐activated receptor‐γ. The Anatomical Record 2020; 303(11): 2801 doi: 10.1002/ar.24350
|
13 |
Dan A. Dixon, Fernando F. Blanco, Annalisa Bruno, Paola Patrignani. Prospects for Chemoprevention of Colorectal Neoplasia. Recent Results in Cancer Research 2013; 191: 7 doi: 10.1007/978-3-642-30331-9_2
|
14 |
Mohamed Sabri Bensaad, Devvret Verma, Debasis Mitra, Mahmoud Helal, Hamsa Jameel Banjer, Ashjan A. Shami, Rokayya Sami, Mamdoh S. Moawadh, Zeyad M. Alharbi, Dania S. Waggas, Fadi Baakdah, Siraj B. AlHarthi. Estimating molecular properties, drug-likeness, cardiotoxic risk, liability profile, and molecular docking study to characterize binding process of key phyto-compounds against serotonin 5-HT2A receptor. Open Chemistry 2024; 22(1) doi: 10.1515/chem-2024-0088
|
15 |
Harini Chowdary Vadlamudi, Prasanna Raju Yalavarthi, Rubia Yasmeen Balambhaigari, Jayasri Vulava. Receptors and ligands role in colon physiology and pathology. Journal of Receptors and Signal Transduction 2013; 33(1): 1 doi: 10.3109/10799893.2012.752001
|
16 |
Valerio Pazienza, Manlio Vinciguerra, Gianluigi Mazzoccoli. PPARs Signaling and Cancer in the Gastrointestinal System. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/560846
|
17 |
Qiang Qu, Jian Qu, Yong Guo, Bo-Ting Zhou, Hong-Hao Zhou. Luteolin potentiates the sensitivity of colorectal cancer cell lines to oxaliplatin through the PPARγ/OCTN2 pathway. Anti-Cancer Drugs 2014; 25(9): 1016 doi: 10.1097/CAD.0000000000000125
|
18 |
Subhankar P. Mandal, Mithuna Mithuna, Aakriti Garg, Sanjana S. Sahetya, S. R. Nagendra, H. S. Sripad, Mendon Manisha Manjunath, Sitaram Sitaram, Mukesh Soni, R. Nasir Baig, S. Vasanth Kumar, B. R. Prashantha Kumar. Novel rhodanines with anticancer activity: design, synthesis and CoMSIA study. RSC Advances 2016; 6(63): 58641 doi: 10.1039/C6RA08785J
|
19 |
Graeme C. McAlister, David P. Nusinow, Mark P. Jedrychowski, Martin Wühr, Edward L. Huttlin, Brian K. Erickson, Ramin Rad, Wilhelm Haas, Steven P. Gygi. MultiNotch MS3 Enables Accurate, Sensitive, and Multiplexed Detection of Differential Expression across Cancer Cell Line Proteomes. Analytical Chemistry 2014; 86(14): 7150 doi: 10.1021/ac502040v
|
20 |
Zuzana Tylichová, Nicol Straková, Jan Vondráček, Alena Hyršlová Vaculová, Alois Kozubík, Jiřina Hofmanová. Activation of autophagy and PPARγ protect colon cancer cells against apoptosis induced by interactive effects of butyrate and DHA in a cell type-dependent manner: The role of cell differentiation. The Journal of Nutritional Biochemistry 2017; 39: 145 doi: 10.1016/j.jnutbio.2016.09.006
|
21 |
Hsiu-Chen Lin, Baxter H. Kachingwe, Hsiu-Li Lin, Hui Wen Cheng, Yow-Shieng Uang, Li-Hsuan Wang. Effects of Metformin Dose on Cancer Risk Reduction in Patients with Type 2 Diabetes Mellitus: A 6-Year Follow-up Study. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2014; 34(1): 36 doi: 10.1002/phar.1334
|
22 |
Harsh Kumar, Aakash Deep, Rakesh Kumar Marwaha. Chemical Synthesis, Mechanism of Action and Anticancer Potential of Medicinally Important Thiazolidin-2,4-dione Derivatives: A Review. Mini-Reviews in Medicinal Chemistry 2019; 19(18): 1474 doi: 10.2174/1389557519666190513093618
|
23 |
Mariafrancesca Scalise, Michele Galluccio, Rosita Accardi, Iris Cornet, Massimo Tommasino, Cesare Indiveri. Human OCTN2 (SLC22A5) is down‐regulated in virus‐ and nonvirus‐mediated cancer. Cell Biochemistry and Function 2012; 30(5): 419 doi: 10.1002/cbf.2816
|
24 |
Akhileshwar Namani, Jing Li, Xiu Jun Wang, Xiuwen Tang. A Review of Compounds for Prevention of Colorectal Cancer. Current Pharmacology Reports 2017; 3(5): 221 doi: 10.1007/s40495-017-0101-6
|
25 |
Tamotsu Tsukahara. The Role of PPARγin the Transcriptional Control by Agonists and Antagonists. PPAR Research 2012; 2012: 1 doi: 10.1155/2012/362361
|
26 |
Youyi Du, Zhuqing Lv, Debin Sun, Yuan Li, Lei Sun, Jiafeng Zhou. RETRACTED: Physcion 8‐O‐β‐Glucopyranoside Exerts Anti‐Tumor Activity Against Non‐Small Cell Lung Cancer by Targeting PPARγ. The Anatomical Record 2019; 302(5): 785 doi: 10.1002/ar.23975
|
27 |
Xiaoyun Tang, Matthew G.K. Benesch, David N. Brindley. Role of the autotaxin–lysophosphatidate axis in the development of resistance to cancer therapy. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2020; 1865(8): 158716 doi: 10.1016/j.bbalip.2020.158716
|
28 |
Yongji Liu, Ling Shi, Yuan Liu, Peng Li, Guoping Jiang, Xiaoning Gao, Yongbin Zhang, Chuanwu Jiang, Weiping Zhu, Hongxing Han, Fang Ju. Activation of PPARγ mediates icaritin-induced cell cycle arrest and apoptosis in glioblastoma multiforme. Biomedicine & Pharmacotherapy 2018; 100: 358 doi: 10.1016/j.biopha.2018.02.006
|
29 |
Ayman M. Mahmoud, Ehab M. Abdella, Azza M. El-Derby, Eman M. Abdella. Protective Effects of Turbinaria ornata
and Padina pavonia
against Azoxymethane-Induced Colon Carcinogenesis through Modulation of PPAR Gamma, NF-κB and Oxidative Stress. Phytotherapy Research 2015; 29(5): 737 doi: 10.1002/ptr.5310
|
30 |
Giuseppina Augimeri, Cinzia Giordano, Luca Gelsomino, Pierluigi Plastina, Ines Barone, Stefania Catalano, Sebastiano Andò, Daniela Bonofiglio. The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies. Cancers 2020; 12(9): 2623 doi: 10.3390/cancers12092623
|
31 |
Kun Li, Qunfeng Guo, Jun Yang, Hui Chen, Kewen Hu, Juan Zhao, Shunxin Zheng, Xiufeng Pang, Sufang Zhou, Yongyan Dang, Lei Li. FOXD3 is a tumor suppressor of colon cancer by inhibiting EGFR-Ras-Raf-MEK-ERK signal pathway. Oncotarget 2017; 8(3): 5048 doi: 10.18632/oncotarget.13790
|
32 |
M. Royan, B. Navidshad. Peroxisome proliferator-activated receptor gamma (PPARγ), a key regulatory gene of lipid metabolism in chicken. World's Poultry Science Journal 2016; 72(4): 773 doi: 10.1017/S0043933916000684
|
33 |
Lucía González-Llorente, Fulvio Santacatterina, Ana García-Aguilar, Cristina Nuevo-Tapioles, Sara González-García, Zuzana Tirpakova, María Luisa Toribio, José M. Cuezva. Overexpression of Mitochondrial IF1 Prevents Metastatic Disease of Colorectal Cancer by Enhancing Anoikis and Tumor Infiltration of NK Cells. Cancers 2019; 12(1): 22 doi: 10.3390/cancers12010022
|
34 |
Zhuo Liu, Xiao Li, Jie Ma, Dechuan Li, Haixing Ju, Yong Liu, Yinbo Chen, Xujun He, Yuping Zhu. <p>Integrative Analysis of the IQ Motif-Containing GTPase-Activating Protein Family Indicates That the IQGAP3-PIK3C2B Axis Promotes Invasion in Colon Cancer</p>. OncoTargets and Therapy 2020; : 8299 doi: 10.2147/OTT.S257729
|